πŸ‡ΊπŸ‡Έ FDA
Patent

US 8227421

Fluorinated GHRH antagonists

granted A61KA61K38/00A61K9/0019

Quick answer

US patent 8227421 (Fluorinated GHRH antagonists) held by The United States of America represented by the Department of Veteran Affairs expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America represented by the Department of Veteran Affairs
Grant date
Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K9/0019, A61P, A61P35/00